4 Robert Speck Parkway 15th Floor,
Mississauga, Ontario ON L4Z 1S1
Vasogen, Inc. is a biotechnology company focused on destructive inflammatory processes associated with the development and progression of cardiovascular and neuro-inflammatory disorders.
Vasogen was acquired by IntelliPharmaCeutics International on October 22, 2009.
Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Vasogen.
No obligation. Cancel anytime.